ofloxacin
MSI-78-303
Phase 3 small_molecule completed
Quick answer
ofloxacin for Diabetic Foot Ulcers is a Phase 3 program (small_molecule) at ABEONA THERAPEUTICS INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- ABEONA THERAPEUTICS INC.
- Indication
- Diabetic Foot Ulcers
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed